← The FDA Ephemeris: the whole map
Vizamyl flutemetamol f-18
Listed: the approval is known from Drugs@FDA; its review documents are not yet in the Ephemeris.
- Application
- NDA 203137
- Sponsor
- GE Healthcare
- Drug class
- Amyloid PET imaging agent
- First approved
- October 25, 2013
- Drugs@FDA status
- Discontinued, Prescription
NDA 203137 on Drugs@FDA
Also amyloid pet imaging agents: Amyvid, Neuraceq
From FDA documents. Not medical advice.